Eric Winer

This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles free of charge to researchers worldwide.

Research Profile (preview)

Disorders

Procedures

Chemicals & Drugs

Concepts & Ideas

Physiology

Postmenopause

Sign-in to see full Profile

Sign-in to see all Coauthors

Publications

TOP 3
Mayer E L; Partridge A H; Harris L N; Gelman R S; Schumer S T; Burstein H J; Winer E P
Tolerability of and adherence to combination oral therapy with gefitinib and capecitabine in metastatic breast cancer.
Keating Nancy L; Kouri Elena; He Yulei; Weeks Jane C; Winer Eric P
Racial differences in definitive breast cancer therapy in older women: are they explained by the hospitals where patients undergo surgery?
Muss Hyman B; Berry Donald A; Cirrincione Constance T; Theodoulou Maria; Mauer Ann M; Kornblith Alice B; Partridge Ann H; Dressler Lynn G; Cohen Harvey J; Becker Heather P; Kartcheske Patricia A; Wheeler Judith D; Perez Edith A; Wolff Antonio C; Gralow Julie R; Burstein Harold J; Mahmood Ahmad A; Magrinat Gustav; Parker Barbara A; Hart Ronald D; Grenier Debjani; Norton Larry; Hudis Clifford A; Winer Eric P;
Adjuvant chemotherapy in older women with early-stage breast cancer.

Sign-in to see all Publications

Sign in free and see...

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the visualized research activity
of experts around the globe

Sign-in to see more

Geonetwork of Eric Winer (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

Sign-in to see more

All Publications

2009: Mayer E L; Partridge A H; Harris L N; Gelman R S; Schumer S T; Burstein H J; Winer E P
Tolerability of and adherence to combination oral therapy with gefitinib and capecitabine in metastatic breast cancer.
Breast cancer research and treatment 2009;117(3):615-23.
2009: Keating Nancy L; Kouri Elena; He Yulei; Weeks Jane C; Winer Eric P
Racial differences in definitive breast cancer therapy in older women: are they explained by the hospitals where patients undergo surgery?
Medical care 2009;47(7):765-73.
2009: Muss Hyman B; Berry Donald A; Cirrincione Constance T; Theodoulou Maria; Mauer Ann M; Kornblith Alice B; Partridge Ann H; Dressler Lynn G; Cohen Harvey J; Becker Heather P; Kartcheske Patricia A; Wheeler Judith D; Perez Edith A; Wolff Antonio C; Gralow Julie R; Burstein Harold J; Mahmood Ahmad A; Magrinat Gustav; Parker Barbara A; Hart Ronald D; Grenier Debjani; Norton Larry; Hudis Clifford A; Winer Eric P;
Adjuvant chemotherapy in older women with early-stage breast cancer.
The New England journal of medicine 2009;360(20):2055-65.
2009: Theodoulou Maria; Batist Gerald; Campos Susana; Winer Eric; Welles Lauri; Hudis Clifford
Phase I study of nonpegylated liposomal doxorubicin plus trastuzumab in patients with HER2-positive breast cancer.
Clinical breast cancer 2009;9(2):101-7.
2009: Bafford Andrea C; Burstein Harold J; Barkley Christina R; Smith Barbara L; Lipsitz Stuart; Iglehart James D; Winer Eric P; Golshan Mehra
Breast surgery in stage IV breast cancer: impact of staging and patient selection on overall survival.
Breast cancer research and treatment 2009;115(1):7-12.
2009: Partridge Ann H; Wolff A C; Marcom P K; Kaufman P A; Zhang L; Gelman R; Moore C; Lake D; Fleming G F; Rugo H S; Atkins J; Sampson E; Collyar D; Winer E P
The impact of sharing results of a randomized breast cancer clinical trial with study participants.
Breast cancer research and treatment 2009;115(1):123-9.
2009: Dickler Maura N; Cobleigh Melody A; Miller Kathy D; Klein Pamela M; Winer Eric P
Efficacy and safety of erlotinib in patients with locally advanced or metastatic breast cancer.
Breast cancer research and treatment 2009;115(1):115-21.
2009: Campos Susana M; Guastalla Jean Paul; Subar Milayna; Abreu Paula; Winer Eric P; Cameron David A
A comparative study of exemestane versus anastrozole in patients with postmenopausal breast cancer with visceral metastases.
Clinical breast cancer 2009;9(1):39-44.
2009: Lin Nancy U; Diéras Véronique; Paul Devchand; Lossignol Dominique; Christodoulou Christos; Stemmler Hans-Joachim; Roché Henri; Liu Minetta C; Greil Richard; Ciruelos Eva; Loibl Sibylle; Gori Stefania; Wardley Andrew; Yardley Denise; Brufsky Adam; Blum Joanne L; Rubin Stephen D; Dharan Bernie; Steplewski Klaudia; Zembryki Denise; Oliva Cristina; Roychowdhury Debasish; Paoletti Paolo; Winer Eric P
Multicenter phase II study of lapatinib in patients with brain metastases from HER2-positive breast cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 2009;15(4):1452-9.
2009: Carlson Robert W; Allred D Craig; Anderson Benjamin O; Burstein Harold J; Carter W Bradford; Edge Stephen B; Erban John K; Farrar William B; Goldstein Lori J; Gradishar William J; Hayes Daniel F; Hudis Clifford A; Jahanzeb Mohammad; Kiel Krystyna; Ljung Britt-Marie; Marcom P Kelly; Mayer Ingrid A; McCormick Beryl; Nabell Lisle M; Pierce Lori J; Reed Elizabeth C; Smith Mary Lou; Somlo George; Theriault Richard L; Topham Neal S; Ward John H; Winer Eric P; Wolff Antonio C;
Breast cancer. Clinical practice guidelines in oncology.
Journal of the National Comprehensive Cancer Network : JNCCN 2009;7(2):122-92.
2009: Freedman Rachel A; He Yulei; Winer Eric P; Keating Nancy L
Trends in racial and age disparities in definitive local therapy of early-stage breast cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2009;27(5):713-9.
2009: Ligibel Jennifer A; Partridge Ann; Giobbie-Hurder Anita; Golshan Mehra; Emmons Karen; Winer Eric P
Physical activity behaviors in women with newly diagnosed ductal carcinoma-in-situ.
Annals of surgical oncology 2009;16(1):106-12.
2009: Krop Ian E; Winer Eric P
Ten years of HER2-directed therapy: still questions after all these years.
Breast cancer research and treatment 2009;113(2):207-9.
2008: Freedman Rachel A; Winer Eric P
Reducing disparities in breast cancer care: a daunting but essential responsibility.
Journal of the National Cancer Institute 2008;100(23):1661-3.
2008: Lin Nancy U; Claus Elizabeth; Sohl Jessica; Razzak Abdul R; Arnaout Amal; Winer Eric P
Sites of distant recurrence and clinical outcomes in patients with metastatic triple-negative breast cancer: high incidence of central nervous system metastases.
Cancer 2008;113(10):2638-45.
2008: Wong Julia S; Taghian Alphonse G; Bellon Jennifer R; Keshaviah Aparna; Smith Barbara L; Winer Eric P; Silver Barbara; Harris Jay R
Tangential radiotherapy without axillary surgery in early-stage breast cancer: results of a prospective trial.
International journal of radiation oncology, biology, physics 2008;72(3):866-70.
2008: Tolaney Sara M; Najita Julie; Winer Eric P; Burstein Harold J
Lymphopenia associated with adjuvant anthracycline/ taxane regimens.
Clinical breast cancer 2008;8(4):352-6.
2008: Partridge Ann; Winer Jeffrey P; Golshan Mehra; Bellon Jennifer R; Blood Emily; Dees E Claire; Sampson Ebonie; Emmons Karen M; Winer Eric
Perceptions and management approaches of physicians who care for women with ductal carcinoma in situ.
Clinical breast cancer 2008;8(3):275-80.
2008: Polite Blase N; Cirrincione Constance; Fleming Gini F; Berry Donald A; Seidman Andrew; Muss Hyman; Norton Larry; Shapiro Charles; Bakri Kamal; Marcom Kelly; Lake Diana; Schwartz Joel H; Hudis Clifford; Winer Eric P
Racial differences in clinical outcomes from metastatic breast cancer: a pooled analysis of CALGB 9342 and 9840--Cancer and Leukemia Group B.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2008;26(16):2659-65.
2008: Punglia Rinaa S; Burstein Harold J; Winer Eric P; Weeks Jane C
Pharmacogenomic variation of CYP2D6 and the choice of optimal adjuvant endocrine therapy for postmenopausal breast cancer: a modeling analysis.
Journal of the National Cancer Institute 2008;100(9):642-8.
2008: Liu Minetta C; Demetri George D; Berry Donald A; Norton Larry; Broadwater Gloria; Robert Nicholas J; Duggan David; Hayes Daniel F; Henderson I Craig; Lyss Alan; Hopkins Judith; Kaufman Peter A; Marcom P Kelly; Younger Jerry; Lin Nancy; Tkaczuk Katherine; Winer Eric P; Hudis Clifford A;
Dose-escalation of filgrastim does not improve efficacy: clinical tolerability and long-term follow-up on CALGB study 9141 adjuvant chemotherapy for node-positive breast cancer patients using dose-intensified doxorubicin plus cyclophosphamide followed by paclitaxel.
Cancer treatment reviews 2008;34(3):223-30.
2008: Lin Nancy U; Carey Lisa A; Liu Minetta C; Younger Jerry; Come Steven E; Ewend Matthew; Harris Gordon J; Bullitt Elizabeth; Van den Abbeele Annick D; Henson John W; Li Xiaochun; Gelman Rebecca; Burstein Harold J; Kasparian Elizabeth; Kirsch David G; Crawford Ann; Hochberg Fred; Winer Eric P
Phase II trial of lapatinib for brain metastases in patients with human epidermal growth factor receptor 2-positive breast cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2008;26(12):1993-9.
2008: Lin Nancy U; Winer Eric P
Optimizing endocrine therapy for estrogen receptor-positive breast cancer: treating the right patients for the right length of time.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2008;26(12):1919-21.
2008: Stokes Michael E; Thompson David; Montoya Eduardo L; Weinstein Milton C; Winer Eric P; Earle Craig C
Ten-year survival and cost following breast cancer recurrence: estimates from SEER-medicare data.
Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research 2008;11(2):213-20.
2008: Perez Edith A; Suman Vera J; Davidson Nancy E; Sledge George W; Kaufman Peter A; Hudis Clifford A; Martino Silvana; Gralow Julie R; Dakhil Shaker R; Ingle James N; Winer Eric P; Gelmon Karen A; Gersh Bernard J; Jaffe Allan S; Rodeheffer Richard J
Cardiac safety analysis of doxorubicin and cyclophosphamide followed by paclitaxel with or without trastuzumab in the North Central Cancer Treatment Group N9831 adjuvant breast cancer trial.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2008;26(8):1231-8.
2008: Partridge Ann H; Gelber Shari; Peppercorn Jeffrey; Ginsburg Elizabeth; Sampson Ebonie; Rosenberg Randi; Przypyszny Michele; Winer Eric P
Fertility and menopausal outcomes in young breast cancer survivors.
Clinical breast cancer 2008;8(1):65-9.
2008: Ligibel Jennifer A; Campbell Nancy; Partridge Ann; Chen Wendy Y; Salinardi Taylor; Chen Haiyan; Adloff Kristie; Keshaviah Aparna; Winer Eric P
Impact of a mixed strength and endurance exercise intervention on insulin levels in breast cancer survivors.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2008;26(6):907-12.
2008: Partridge Ann; Adloff Kristie; Blood Emily; Dees E Claire; Kaelin Carolyn; Golshan Mehra; Ligibel Jennifer; de Moor Janet S; Weeks Jane; Emmons Karen; Winer Eric
Risk perceptions and psychosocial outcomes of women with ductal carcinoma in situ: longitudinal results from a cohort study.
Journal of the National Cancer Institute 2008;100(4):243-51.
2008: Gralow Julie R; Burstein Harold J; Wood William; Hortobagyi Gabriel N; Gianni Luca; von Minckwitz Gunter; Buzdar Aman U; Smith Ian E; Symmans William F; Singh Baljit; Winer Eric P
Preoperative therapy in invasive breast cancer: pathologic assessment and systemic therapy issues in operable disease.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2008;26(5):814-9.
2008: Lin Nancy U; Winer Eric P
Advances in adjuvant endocrine therapy for postmenopausal women.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2008;26(5):798-805.
2008: Partridge Ann H; LaFountain Andrea; Mayer Erica; Taylor Brooke S; Winer Eric; Asnis-Alibozek Aviva
Adherence to initial adjuvant anastrozole therapy among women with early-stage breast cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2008;26(4):556-62.
2008: Buzdar Aman U; Coombes R Charles; Goss Paul E; Winer Eric P
Summary of aromatase inhibitor clinical trials in postmenopausal women with early breast cancer.
Cancer 2008;112(3 Suppl):700-9.
2008: Come Steven E; Buzdar Aman U; Ingle James N; Johnston Stephen R D; Brodie Angela M; Coombes R Charles; Miller William R; Pritchard Kathleen I; Winer Eric P; Zujewski Jo Anne; Goss Paul E
Endocrine and targeted manipulation of breast cancer: summary statement for the Sixth Cambridge Conference.
Cancer 2008;112(3 Suppl):673-8.
2008: Gralow Julie; Ozols Robert F; Bajorin Dean F; Cheson Bruce D; Sandler Howard M; Winer Eric P; Bonner James; Demetri George D; Curran Walter; Ganz Patricia A; Kramer Barnett S; Kris Mark G; Markman Maurie; Mayer Robert J; Raghavan Derek; Ramsey Scott; Reaman Gregory H; Sawaya Raymond; Schuchter Lynn M; Sweetenham John W; Vahdat Linda T; Davidson Nancy E; Schilsky Richard L; Lichter Allen S;
Clinical cancer advances 2007: major research advances in cancer treatment, prevention, and screening--a report from the American Society of Clinical Oncology.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2008;26(2):313-25.
2008: Keating Nancy L; Landrum Mary Beth; Guadagnoli Edward; Winer Eric P; Ayanian John Z
Care in the months before death and hospice enrollment among older women with advanced breast cancer.
Journal of general internal medicine 2008;23(1):11-8.
2008: Carlson Robert W; Moench Susan; Hurria Arti; Balducci Lodovico; Burstein Harold J; Goldstein Lori J; Gradishar William J; Hughes Kevin S; Jahanzeb Mohammad; Lichtman Stuart M; Marks Lawrence B; McClure Joan S; McCormick Beryl; Nabell Lisle M; Pierce Lori J; Smith Mary Lou; Topham Neal S; Traina Tiffany A; Ward John H; Winer Eric P
NCCN Task Force Report: breast cancer in the older woman.
Journal of the National Comprehensive Cancer Network : JNCCN 2008;6 Suppl 4():S1-S25; quiz S26-S27.
2008: Razzak A Rab; Lin Nancy U; Winer Eric P
Heterogeneity of breast cancer and implications of adjuvant chemotherapy.
Breast cancer (Tokyo, Japan) 2008;15(1):31-4.
2007: Bullitt Elizabeth; Lin Nancy U; Smith J Keith; Zeng Donglin; Winer Eric P; Carey Lisa A; Lin Weili; Ewend Matthew G
Blood vessel morphologic changes depicted with MR angiography during treatment of brain metastases: a feasibility study.
Radiology 2007;245(3):824-30.
2007: Tolaney Sara M; Winer Eric P
Follow-up care of patients with breast cancer.
Breast (Edinburgh, Scotland) 2007;16 Suppl 2():S45-50.
2007: Tolaney Sara M; Colson Yolanda L; Gill Ritu R; Schulte Stephanie; Duggan Margaret M; Shulman Lawrence N; Winer Eric P
Sarcoidosis mimicking metastatic breast cancer.
Clinical breast cancer 2007;7(10):804-10.
2007: Winer Eric P; Harris Jay R; Smith Barbara L; D'Alessandro Helen Anne; Brachtel Elena F
Case records of the Massachusetts General Hospital. Case 32-2007. A 62-year-old woman with a second breast cancer.
The New England journal of medicine 2007;357(16):1640-8.
2007: Hayes Daniel F; Thor Ann D; Dressler Lynn G; Weaver Donald; Edgerton Susan; Cowan David; Broadwater Gloria; Goldstein Lori J; Martino Silvana; Ingle James N; Henderson I Craig; Norton Larry; Winer Eric P; Hudis Clifford A; Ellis Matthew J; Berry Donald A;
HER2 and response to paclitaxel in node-positive breast cancer.
The New England journal of medicine 2007;357(15):1496-506.
2007: Kornblith Alice B; Powell Mark; Regan Meredith M; Bennett Samantha; Krasner Carolyn; Moy Beverly; Younger Jerry; Goodman Annekathyrn; Berkowitz Ross; Winer Eric
Long-term psychosocial adjustment of older vs younger survivors of breast and endometrial cancer.
Psycho-oncology 2007;16(10):895-903.
2007: Thompson David; Taylor Douglas C A; Montoya Eduardo L; Winer Eric P; Jones Stephen E; Weinstein Milton C
Cost-effectiveness of switching to exemestane after 2 to 3 years of therapy with tamoxifen in postmenopausal women with early-stage breast cancer.
Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research 2007;10(5):367-76.
2007: Burstein Harold J; Winer Eric P
Aromatase inhibitors and arthralgias: a new frontier in symptom management for breast cancer survivors.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2007;25(25):3797-9.
2007: Burstein Harold J; Keshaviah Aparna; Baron Ari D; Hart Ronald D; Lambert-Falls Rosemary; Marcom P Kelly; Gelman Rebecca; Winer Eric P
Trastuzumab plus vinorelbine or taxane chemotherapy for HER2-overexpressing metastatic breast cancer: the trastuzumab and vinorelbine or taxane study.
Cancer 2007;110(5):965-72.
2007: Muss Hyman B; Berry Donald A; Cirrincione Constance; Budman Daniel R; Henderson I Craig; Citron Marc L; Norton Larry; Winer Eric P; Hudis Clifford A;
Toxicity of older and younger patients treated with adjuvant chemotherapy for node-positive breast cancer: the Cancer and Leukemia Group B Experience.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2007;25(24):3699-704.
2007: Lin Nancy U; Parker Leroy M; Come Steven E; Burstein Harold J; Haldoupis Margaret; Ryabin Nicole; Gelman Rebecca; Winer Eric P; Shulman Lawrence N
Phase II study of CT-2103 as first- or second-line chemotherapy in patients with metastatic breast cancer: unexpected incidence of hypersensitivity reactions.
Investigational new drugs 2007;25(4):369-75.
2007: Lin Nancy U; Winer Eric P
Optimal use of aromatase inhibitors: to lead or to follow?
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2007;25(19):2639-41.
2007: Partridge Ann; Gelber Shari; Gelber Richard D; Castiglione-Gertsch Monica; Goldhirsch Aron; Winer Eric
Age of menopause among women who remain premenopausal following treatment for early breast cancer: long-term results from International Breast Cancer Study Group Trials V and VI.
European journal of cancer (Oxford, England : 1990) 2007;43(11):1646-53.
2007: Punglia Rinaa S; Morrow Monica; Winer Eric P; Harris Jay R
Local therapy and survival in breast cancer.
The New England journal of medicine 2007;356(23):2399-405.
2007: Ponte Patricia Reid; Gross Anne H; Winer Eric; Connaughton Mary J; Hassinger James
Implementing an interdisciplinary governance model in a comprehensive cancer center.
Oncology nursing forum 2007;34(3):611-6.
2007: Peppercorn Jeffrey; Blood Emily; Winer Eric; Partridge Ann
Association between pharmaceutical involvement and outcomes in breast cancer clinical trials.
Cancer 2007;109(7):1239-46.
2007: Burstein Harold J; Overmoyer Beth; Gelman Rebecca; Silverman Paula; Savoie Jennifer; Clarke Kathryn; Dumadag Leda; Younger Jerry; Ivy Percy; Winer Eric P
Rebeccamycin analog for refractory breast cancer: a randomized phase II trial of dosing schedules.
Investigational new drugs 2007;25(2):161-4.
2007: Carlson Robert W; Anderson Benjamin O; Burstein Harold J; Carter W Bradford; Edge Stephen B; Farrar William B; Goldstein Lori J; Gradishar William J; Hayes Daniel F; Hudis Clifford A; Jahanzeb Mohammad; Ljung Britt-Marie; Kiel Krystyna; Marks Lawrence B; McCormick Beryl; Nabell Lisle M; Pierce Lori J; Reed Elizabeth C; Silver Samuel M; Smith Mary Lou; Somlo George; Theriault Richard L; Ward John H; Winer Eric P; Wolff Antonio C
Invasive breast cancer.
Journal of the National Comprehensive Cancer Network : JNCCN 2007;5(3):246-312.
2007: Keating Nancy L; Landrum Mary Beth; Guadagnoli Edward; Winer Eric P; Ayanian John Z
Surveillance testing among survivors of early-stage breast cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2007;25(9):1074-81.
2007: Lin Nancy U; Winer Eric P
Brain metastases: the HER2 paradigm.
Clinical cancer research : an official journal of the American Association for Cancer Research 2007;13(6):1648-55.
2007: Harris Lyndsay N; You Fanglei; Schnitt Stuart J; Witkiewicz Agnes; Lu Xin; Sgroi Dennis; Ryan Paula D; Come Steven E; Burstein Harold J; Lesnikoski Beth-Ann; Kamma Madhavi; Friedman Paula N; Gelman Rebecca; Iglehart J Dirk; Winer Eric P
Predictors of resistance to preoperative trastuzumab and vinorelbine for HER2-positive early breast cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 2007;13(4):1198-207.
2006: Leining M G; Gelber S; Rosenberg R; Przypyszny M; Winer E P; Partridge A H
Menopausal-type symptoms in young breast cancer survivors.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2006;17(12):1777-82.
2006: Rincon Mercedes; Broadwater Gloria; Harris Lyndsay; Crocker Abigail; Weaver Donald; Dressler Lynn; Berry Donald; Sutton Linda; Michaelson Richard; Messino Michael; Kirshner Jeffrey; Fleming Gini; Winer Eric; Hudis Clifford; Appel Stacy; Norton Larry; Muss Hyman;
Interleukin-6, multidrug resistance protein-1 expression and response to paclitaxel in women with metastatic breast cancer: results of cancer and leukemia group B trial 159806.
Breast cancer research and treatment 2006;100(3):301-8.
2006: Tolaney Sara M; Partridge Ann H; Sheib Rochelle G; Burstein Harold J; Winer Eric P
Pneumocystis carinii pneumonia during dose-dense chemotherapy for breast cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2006;24(33):5330-1.
2006: Kornblith Alice B; Regan Meredith M; Kim Youngmee; Greer Greta; Parker Beverly; Bennett Samantha; Winer Eric
Cancer-related communication between female patients and male partners scale: A pilot study.
Psycho-oncology 2006;15(9):780-94.
2006: Carlson Robert W; Moench Susan J; Hammond M Elizabeth H; Perez Edith A; Burstein Harold J; Allred D Craig; Vogel Charles L; Goldstein Lori J; Somlo George; Gradishar William J; Hudis Clifford A; Jahanzeb Mohammad; Stark Azadeh; Wolff Antonio C; Press Michael F; Winer Eric P; Paik Soonmyung; Ljung Britt-Marie;
HER2 testing in breast cancer: NCCN Task Force report and recommendations.
Journal of the National Comprehensive Cancer Network : JNCCN 2006;4 Suppl 3():S1-22; quiz S23-4.
2006: Hudis Clifford A; Winer Eric P
Cancer and leukemia group B breast committee: decades of progress and plans for the future.
Clinical cancer research : an official journal of the American Association for Cancer Research 2006;12(11 Pt 2):3576s-80s.
2006: Punglia Rinaa S; Kuntz Karen M; Winer Eric P; Weeks Jane C; Burstein Harold J
The impact of tumor progesterone receptor status on optimal adjuvant endocrine therapy for postmenopausal patients with early-stage breast cancer: a decision analysis.
Cancer 2006;106(12):2576-82.
2006: Berry Donald A; Cirrincione Constance; Henderson I Craig; Citron Marc L; Budman Daniel R; Goldstein Lori J; Martino Silvana; Perez Edith A; Muss Hyman B; Norton Larry; Hudis Clifford; Winer Eric P
Estrogen-receptor status and outcomes of modern chemotherapy for patients with node-positive breast cancer.
JAMA : the journal of the American Medical Association 2006;295(14):1658-67.
2006: Carlson Robert W; Brown Elizabeth; Burstein Harold J; Gradishar William J; Hudis Clifford A; Loprinzi Charles; Mamounas Eleftherios Paul; Perez Edith A; Pritchard Kathleen; Ravdin Peter; Recht Abram; Somlo George; Theriault Richard L; Winer Eric P; Wolff Antonio C;
NCCN Task Force Report: Adjuvant Therapy for Breast Cancer.
Journal of the National Comprehensive Cancer Network : JNCCN 2006;4 Suppl 1():S1-26.
2006: Come Steven E; Buzdar Aman U; Ingle James N; Arteaga Carlos L; Brown Myles; Dowsett Mitch; Hilsenbeck Susan G; Kumar Rakesh; Johnston Stephen R D; Lee Adrian V; Paik Soonmyung; Pritchard Kathleen I; Winer Eric P; Hart Carol
Proceedings of the Fifth International Conference on Recent Advances and Future Directions in Endocrine Therapy for Breast Cancer: conference summary statement.
Clinical cancer research : an official journal of the American Association for Cancer Research 2006;12(3 Pt 2):997s-1000s.
2006: Burstein Harold J; Bellon Jennifer R; Galper Sharon; Lu Hsiao-Ming; Kuter Irene; Taghian Alphonse G; Wong Julia; Gelman Rebecca; Bunnell Craig A; Parker Leroy M; Garber Judy E; Winer Eric P; Harris Jay R; Powell Simon N
Prospective evaluation of concurrent paclitaxel and radiation therapy after adjuvant doxorubicin and cyclophosphamide chemotherapy for Stage II or III breast cancer.
International journal of radiation oncology, biology, physics 2006;64(2):496-504.
2006: Ligibel Jennifer A; Winer Eric P
Aromatase inhibitors in the adjuvant treatment of postmenopausal women with early stage breast cancer.
Women's health (London, England) 2006;2(1):89-97.
2006: Keating Nancy L; Landrum Mary Beth; Guadagnoli Edward; Winer Eric P; Ayanian John Z
Factors related to underuse of surveillance mammography among breast cancer survivors.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2006;24(1):85-94.
2006: Bullitt Elizabeth; Lin Nancy U; Ewend Matthew G; Zeng Donglin; Winer Eric P; Carey Lisa A; Smith J Keith
Tumor therapeutic response and vessel tortuosity: preliminary report in metastatic breast cancer.
Medical image computing and computer-assisted intervention : MICCAI ... International Conference on Medical Image Computing and Computer-Assisted Intervention 2006;9(Pt 2):561-8.
2006: Harris Lyndsay N; Broadwater Gloria; Lin Nancy U; Miron Alexander; Schnitt Stuart J; Cowan David; Lara Jonathan; Bleiweiss Ira; Berry Donald; Ellis Matthew; Hayes Daniel F; Winer Eric P; Dressler Lynn
Molecular subtypes of breast cancer in relation to paclitaxel response and outcomes in women with metastatic disease: results from CALGB 9342.
Breast cancer research : BCR 2006;8(6):R66.
2005: Lin Nancy U; Gelman Rebecca; Winer Eric P
Dose density in breast cancer: a simple message?
Journal of the National Cancer Institute 2005;97(23):1712-4.
2005: Peppercorn Jeffery; Partridge Ann; Burstein Harold J; Winer Eric P
Standards for follow-up care of patents with breast cancer.
Breast (Edinburgh, Scotland) 2005;14(6):500-8.
2005: Meyerhardt Jeffrey A; Heseltine Denise; Campos Hannia; Holmes Michelle D; Willett Walter C; Winer Eric P; Enzinger Peter C; Bunnell Craig A; Kulke Matthew H; Fuchs Charles S
Assessment of a dietary questionnaire in cancer patients receiving cytotoxic chemotherapy.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2005;23(33):8453-60.
2005: Burstein Harold J; Parker Leroy M; Keshaviah Aparna; Doherty Jennifer; Partridge Ann H; Schapira Lidia; Ryan Paula D; Younger Jerry; Harris Lyndsay N; Moy Beverly; Come Steven E; Schumer Susan T; Bunnell Craig A; Haldoupis Margaret; Gelman Rebecca; Winer Eric P
Efficacy of pegfilgrastim and darbepoetin alfa as hematopoietic support for dose-dense every-2-week adjuvant breast cancer chemotherapy.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2005;23(33):8340-7.
2005: Burstein H J; Lieberman G; Slamon D J; Winer E P; Klein P
Isolated central nervous system metastases in patients with HER2-overexpressing advanced breast cancer treated with first-line trastuzumab-based therapy.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2005;16(11):1772-7.
2005: Lyman Gary H; Giuliano Armando E; Somerfield Mark R; Benson Al B; Bodurka Diane C; Burstein Harold J; Cochran Alistair J; Cody Hiram S; Edge Stephen B; Galper Sharon; Hayman James A; Kim Theodore Y; Perkins Cheryl L; Podoloff Donald A; Sivasubramaniam Visa Haran; Turner Roderick R; Wahl Richard; Weaver Donald L; Wolff Antonio C; Winer Eric P;
American Society of Clinical Oncology guideline recommendations for sentinel lymph node biopsy in early-stage breast cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2005;23(30):7703-20.
2005: Peppercorn Jeffrey; Herndon James; Kornblith Alice B; Peters William; Ahles Tim; Vredenburgh James; Schwartz Gary; Shpall Elizabeth; Hurd David D; Holland Jimmie; Winer Eric
Quality of life among patients with Stage II and III breast carcinoma randomized to receive high-dose chemotherapy with autologous bone marrow support or intermediate-dose chemotherapy: results from Cancer and Leukemia Group B 9066.
Cancer 2005;104(8):1580-9.
2005: Krop Ian E; Winer Eric P
Ovarian suppression for breast cancer: an effective treatment in search of a home.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2005;23(25):5869-72.
2005: Punglia Rinaa S; Kuntz Karen M; Winer Eric P; Weeks Jane C; Burstein Harold J
Optimizing adjuvant endocrine therapy in postmenopausal women with early-stage breast cancer: a decision analysis.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2005;23(22):5178-87.
2005: Partridge Ann H; Winer Eric P
Fertility after breast cancer: questions abound.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2005;23(19):4259-61.
2005: Burstein Harold J; Winer Eric P
HER2 or not HER2: that is the question.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2005;23(16):3656-9.
2005: Carlson Robert W; Anderson Benjamin O; Burstein Harold J; Cox Charles E; Edge Stephen B; Farrar William B; Goldstein Lori J; Gradishar William J; Hayes Daniel F; Hudis Clifford; Jahanzeb Mohammad; Ljung Britt-Marie; Marks Lawrence B; McCormick Beryl; Nabell Lisle M; Pierce Lori J; Reed Elizabeth C; Silver Samuel M; Smith Mary Lou; Somlo George; Theriault Richard L; Ward John H; Winer Eric P; Wolff Antonio C;
Breast cancer.
Journal of the National Comprehensive Cancer Network : JNCCN 2005;3(3):238-89.
2005: Partridge Ann H; Wong Julia S; Knudsen Katherine; Gelman Rebecca; Sampson Ebonie; Gadd Michele; Bishop Karyn L; Harris Jay R; Winer Eric P
Offering participants results of a clinical trial: sharing results of a negative study.
Lancet 2005;365(9463):963-4.
2005: Winer Eric P
Optimizing endocrine therapy for breast cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2005;23(8):1609-10.
2005: Muss Hyman B; Woolf Susan; Berry Donald; Cirrincione Constance; Weiss Raymond B; Budman Daniel; Wood William C; Henderson I Craig; Hudis Clifford; Winer Eric; Cohen Harvey; Wheeler Judith; Norton Larry;
Adjuvant chemotherapy in older and younger women with lymph node-positive breast cancer.
JAMA : the journal of the American Medical Association 2005;293(9):1073-81.
2005: Galper Sharon; Blood Emily; Gelman Rebecca; Abner Anthony; Recht Abram; Kohli Anita; Wong Julia S; Smith Darrell; Bellon Jennifer; Connolly James; Schnitt Stuart; Winer Eric; Silver Barbara; Harris Jay R
Prognosis after local recurrence after conservative surgery and radiation for early-stage breast cancer.
International journal of radiation oncology, biology, physics 2005;61(2):348-57.
2005: Wittenberg Eve; Winer Eric P; Weeks Jane C
Patient utilities for advanced cancer: effect of current health on values.
Medical care 2005;43(2):173-81.
2005: Keating Nancy L; Landrum Mary Beth; Ayanian John Z; Winer Eric P; Guadagnoli Edward
The association of ambulatory care with breast cancer stage at diagnosis among Medicare beneficiaries.
Journal of general internal medicine 2005;20(1):38-44.
2005: Winer Eric P; Hudis Clifford; Burstein Harold J; Wolff Antonio C; Pritchard Kathleen I; Ingle James N; Chlebowski Rowan T; Gelber Richard; Edge Stephan B; Gralow Julie; Cobleigh Melody A; Mamounas Eleftherios P; Goldstein Lori J; Whelan Timothy J; Powles Trevor J; Bryant John; Perkins Cheryl; Perotti Judy; Braun Susan; Langer Amy S; Browman George P; Somerfield Mark R
American Society of Clinical Oncology technology assessment on the use of aromatase inhibitors as adjuvant therapy for postmenopausal women with hormone receptor-positive breast cancer: status report 2004.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2005;23(3):619-29.
2005: Ligibel Jennifer A; Winer Eric P
Aromatase inhibitors as adjuvant therapy for postmenopausal women: a therapeutic advance but many unresolved questions.
Breast cancer research : BCR 2005;7(6):255-7.
2004: Robert Nicholas J; Vogel Charles L; Henderson I Craig; Sparano Joseph A; Moore Melvin R; Silverman Paula; Overmoyer Beth A; Shapiro Charles L; Park John W; Colbern Gail T; Winer Eric P; Gabizon Alberto A
The role of the liposomal anthracyclines and other systemic therapies in the management of advanced breast cancer.
Seminars in oncology 2004;31(6 Suppl 13):106-46.
2004: Alberts David S; Muggia Franco M; Carmichael James; Winer Eric P; Jahanzeb Mohammad; Venook Alan P; Skubitz Keith M; Rivera Edgardo; Sparano Joseph A; DiBella Nicholas J; Stewart Simon J; Kavanagh John J; Gabizon Alberto A
Efficacy and safety of liposomal anthracyclines in phase I/II clinical trials.
Seminars in oncology 2004;31(6 Suppl 13):53-90.
2004: Partridge Ann H; Gelber Shari; Peppercorn Jeffrey; Sampson Ebonie; Knudsen Katherine; Laufer Marc; Rosenberg Randi; Przypyszny Michele; Rein Alison; Winer Eric P
Web-based survey of fertility issues in young women with breast cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2004;22(20):4174-83.
2004: Hughes Kevin S; Schnaper Lauren A; Berry Donald; Cirrincione Constance; McCormick Beryl; Shank Brenda; Wheeler Judith; Champion Lorraine A; Smith Thomas J; Smith Barbara L; Shapiro Charles; Muss Hyman B; Winer Eric; Hudis Clifford; Wood William; Sugarbaker David; Henderson I Craig; Norton Larry;
Lumpectomy plus tamoxifen with or without irradiation in women 70 years of age or older with early breast cancer.
The New England journal of medicine 2004;351(10):971-7.
2004: Lin Nancy U; Bellon Jennifer R; Winer Eric P
CNS metastases in breast cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2004;22(17):3608-17.
2004: Winer Eric P; Berry Donald A; Woolf Susan; Duggan David; Kornblith Alice; Harris Lyndsay N; Michaelson Richard A; Kirshner Jeffrey A; Fleming Gini F; Perry Michael C; Graham Mark L; Sharp Stewart A; Keresztes Roger; Henderson I Craig; Hudis Clifford; Muss Hyman; Norton Larry
Failure of higher-dose paclitaxel to improve outcome in patients with metastatic breast cancer: cancer and leukemia group B trial 9342.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2004;22(11):2061-8.
2004: Partridge Ann H; Hackett Nadia; Blood Emily; Gelman Rebecca; Joffe Steven; Bauer-Wu Susan; Knudsen Katherine; Emmons Karen; Collyar Deborah; Schilsky Richard L; Winer Eric P
Oncology physician and nurse practices and attitudes regarding offering clinical trial results to study participants.
Journal of the National Cancer Institute 2004;96(8):629-32.
2004: Elkin Elena B; Weinstein Milton C; Winer Eric P; Kuntz Karen M; Schnitt Stuart J; Weeks Jane C
HER-2 testing and trastuzumab therapy for metastatic breast cancer: a cost-effectiveness analysis.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2004;22(5):854-63.
2004: Partridge Ann H; Winer Eric P
Long-term complications of adjuvant chemotherapy for early stage breast cancer.
Breast disease 2004;21():55-64.
2004: Lin Nancy U; Winer Eric P
New targets for therapy in breast cancer: small molecule tyrosine kinase inhibitors.
Breast cancer research : BCR 2004;6(5):204-10.
2003: Keating Nancy L; Landrum Mary Beth; Ayanian John Z; Winer Eric P; Guadagnoli Edward
Consultation with a medical oncologist before surgery and type of surgery among elderly women with early-stage breast cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2003;21(24):4532-9.
2003: Partridge Ann H; Winer Eric P; Burstein Harold J
Follow-up care of breast cancer survivors.
Seminars in oncology 2003;30(6):817-25.
2003: Schuchter Lynn; Meropol Neal J; Winer Eric P; Hensley Martee L; Somerfield Mark R;
Amifostine and chemoradiation therapy: ASCO responds.
The lancet oncology 2003;4(10):593.
2003: Burstein Harold J; Harris Lyndsay N; Marcom P Kelly; Lambert-Falls Rosemary; Havlin Kathleen; Overmoyer Beth; Friedlander Robert J; Gargiulo Janet; Strenger Rochelle; Vogel Charles L; Ryan Paula D; Ellis Mathew J; Nunes Raquel A; Bunnell Craig A; Campos Susana M; Hallor Michele; Gelman Rebecca; Winer Eric P
Trastuzumab and vinorelbine as first-line therapy for HER2-overexpressing metastatic breast cancer: multicenter phase II trial with clinical outcomes, analysis of serum tumor markers as predictive factors, and cardiac surveillance algorithm.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2003;21(15):2889-95.
2003: Bluman Leslie G; Rimer Barbara K; Regan Sterba Katherine; Lancaster Julia; Clark Shelly; Borstelmann Nancy; Iglehart J Dirk; Winer Eric P
Attitudes, knowledge, risk perceptions and decision-making among women with breast and/or ovarian cancer considering testing for BRCA1 and BRCA2 and their spouses.
Psycho-oncology 2003;12(5):410-27.
2003: Winer Eric P; Hudis Clifford; Burstein Harold J; Bryant John; Chlebowski Rowan T; Ingle James N; Edge Stephen B; Mamounas Eleftherios P; Gelber Richard; Gralow Julie; Goldstein Lori J; Pritchard Kathleen I; Braun Susan; Cobleigh Melody A; Langer Amy S; Perotti Judy; Powles Trevor J; Whelan Timothy J; Browman George P
American Society of Clinical Oncology technology assessment working group update: use of aromatase inhibitors in the adjuvant setting.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2003;21(13):2597-9.
2003: Burstein Harold J; Demetri George D; Mueller Elisabetta; Sarraf Pasha; Spiegelman Bruce M; Winer Eric P
Use of the peroxisome proliferator-activated receptor (PPAR) gamma ligand troglitazone as treatment for refractory breast cancer: a phase II study.
Breast cancer research and treatment 2003;79(3):391-7.
2003: Bendell Johanna C; Domchek Susan M; Burstein Harold J; Harris Lyndsay; Younger Jerry; Kuter Irene; Bunnell Craig; Rue Montse; Gelman Rebecca; Winer Eric
Central nervous system metastases in women who receive trastuzumab-based therapy for metastatic breast carcinoma.
Cancer 2003;97(12):2972-7.
2003: Ligibel Jennifer A; Winer Eric P
The aromatase inhibitors as adjuvant therapy for hormone receptor-positive breast cancer.
Journal of the National Comprehensive Cancer Network : JNCCN 2003;1(2):215-21.
2003: Earle Craig C; Burstein Harold J; Winer Eric P; Weeks Jane C
Quality of non-breast cancer health maintenance among elderly breast cancer survivors.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2003;21(8):1447-51.
2003: Citron Marc L; Berry Donald A; Cirrincione Constance; Hudis Clifford; Winer Eric P; Gradishar William J; Davidson Nancy E; Martino Silvana; Livingston Robert; Ingle James N; Perez Edith A; Carpenter John; Hurd David; Holland James F; Smith Barbara L; Sartor Carolyn I; Leung Eleanor H; Abrams Jeffrey; Schilsky Richard L; Muss Hyman B; Norton Larry
Randomized trial of dose-dense versus conventionally scheduled and sequential versus concurrent combination chemotherapy as postoperative adjuvant treatment of node-positive primary breast cancer: first report of Intergroup Trial C9741/Cancer and Leukemia Group B Trial 9741.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2003;21(8):1431-9.
2003: Partridge Ann H; Burstein Harold J; Gelman Rebecca S; Marcom P Kelly; Winer Eric P
Do patients participating in clinical trials want to know study results?
Journal of the National Cancer Institute 2003;95(6):491-2.
2003: Buzdar Aman; O'Shaughnessy Joyce A; Booser Daniel J; Pippen John E; Jones Stephen E; Munster Pamela N; Peterson Patrick; Melemed Allen S; Winer Eric; Hudis Clifford
Phase II, randomized, double-blind study of two dose levels of arzoxifene in patients with locally advanced or metastatic breast cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2003;21(6):1007-14.
2003: Partridge Ann H; Wang Philip S; Winer Eric P; Avorn Jerry
Nonadherence to adjuvant tamoxifen therapy in women with primary breast cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2003;21(4):602-6.
2003: Ligibel Jennifer A; Winer Eric P
Clinical differences among the aromatase inhibitors.
Clinical cancer research : an official journal of the American Association for Cancer Research 2003;9(1 Pt 2):473S-9S.
2003: Come Steven E; Buzdar Aman U; Arteaga Carlos L; Brodie Angela M; Davidson Nancy E; Dowsett Mitch; Ingle James N; Johnston Stephen R D; Lee Adrian V; Osborne C Kent; Pritchard Kathleen I; Vogel Victor G; Winer Eric P; Hart Carol S
Second International Conference on Recent Advances and Future Directions in Endocrine Manipulation of Breast Cancer: summary consensus statement.
Clinical cancer research : an official journal of the American Association for Cancer Research 2003;9(1 Pt 2):443S-6S.
2003: Burstein Harold J; Harris Lyndsay N; Gelman Rebecca; Lester Susan C; Nunes Raquel A; Kaelin Carolyn M; Parker Leroy M; Ellisen Leif W; Kuter Irene; Gadd Michele A; Christian Roger L; Kennedy Patricia Rae; Borges Virginia F; Bunnell Craig A; Younger Jerry; Smith Barbara L; Winer Eric P
Preoperative therapy with trastuzumab and paclitaxel followed by sequential adjuvant doxorubicin/cyclophosphamide for HER2 overexpressing stage II or III breast cancer: a pilot study.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2003;21(1):46-53.
2003: Campos Susana M; Winer Eric P
Hormonal therapy in postmenopausal women with breast cancer.
Oncology 2003;64(4):289-99.
2002: DiGianni Lisa M; Garber Judy E; Winer Eric P
Complementary and alternative medicine use among women with breast cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2002;20(18 Suppl):34S-8S.
2002: Bunnell Craig A; Winer Eric P
Lumping versus splitting: the splitters take this round.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2002;20(17):3576-7.
2002: Chlebowski Rowan T; Col Nananda; Winer Eric P; Collyar Deborah E; Cummings Steven R; Vogel Victor G; Burstein Harold J; Eisen Andrea; Lipkus Isaac; Pfister David G;
American Society of Clinical Oncology technology assessment of pharmacologic interventions for breast cancer risk reduction including tamoxifen, raloxifene, and aromatase inhibition.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2002;20(15):3328-43.
2002: Winer Eric P; Hudis Clifford; Burstein Harold J; Chlebowski Rowan T; Ingle James N; Edge Stephen B; Mamounas Eleftherios P; Gralow Julie; Goldstein Lori J; Pritchard Kathleen I; Braun Susan; Cobleigh Melody A; Langer Amy S; Perotti Judy; Powles Trevor J; Whelan Timothy J; Browman George P
American Society of Clinical Oncology technology assessment on the use of aromatase inhibitors as adjuvant therapy for women with hormone receptor-positive breast cancer: status report 2002.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2002;20(15):3317-27.
2002: Partridge Ann H; Winer Eric P
Informing clinical trial participants about study results.
JAMA : the journal of the American Medical Association 2002;288(3):363-5.
2002: Ligibel Jennifer A; Winer Eric P
Trastuzumab/chemotherapy combinations in metastatic breast cancer.
Seminars in oncology 2002;29(3 Suppl 11):38-43.
2002: Schuchter Lynn M; Hensley Martee L; Meropol Neal J; Winer Eric P;
2002 update of recommendations for the use of chemotherapy and radiotherapy protectants: clinical practice guidelines of the American Society of Clinical Oncology.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2002;20(12):2895-903.
2002: Partridge Ann H; Avorn Jerry; Wang Philip S; Winer Eric P
Adherence to therapy with oral antineoplastic agents.
Journal of the National Cancer Institute 2002;94(9):652-61.
2002: Harris Lyndsay; Batist Gerald; Belt Robert; Rovira Douglas; Navari Rudolph; Azarnia Nozar; Welles Lauri; Winer Eric;
Liposome-encapsulated doxorubicin compared with conventional doxorubicin in a randomized multicenter trial as first-line therapy of metastatic breast carcinoma.
Cancer 2002;94(1):25-36.
2002: Skinner Celette Sugg; Schildkraut Joellen M; Berry Donald; Calingaert Brian; Marcom P Kelly; Sugarman Jeremy; Winer Eric P; Iglehart J Dirk; Futreal P Andrew; Rimer Barbara K
Pre-counseling education materials for BRCA testing: does tailoring make a difference?
Genetic testing 2002;6(2):93-105.
2001: Sparano J A; Winer E P
Liposomal anthracyclines for breast cancer.
Seminars in oncology 2001;28(4 Suppl 12):32-40.
2001: Burstein H J; Bunnell C A; Winer E P
New cytotoxic agents and schedules for advanced breast cancer.
Seminars in oncology 2001;28(4):344-58.
2001: Bluman L G; Borstelmann N A; Rimer B K; Iglehart J D; Winer E P
Knowledge, satisfaction, and perceived cancer risk among women diagnosed with ductal carcinoma in situ.
Journal of women's health & gender-based medicine 2001;10(6):589-98.
2001: Burstein H J; Kuter I; Campos S M; Gelman R S; Tribou L; Parker L M; Manola J; Younger J; Matulonis U; Bunnell C A; Partridge A H; Richardson P G; Clarke K; Shulman L N; Winer E P
Clinical activity of trastuzumab and vinorelbine in women with HER2-overexpressing metastatic breast cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2001;19(10):2722-30.
2001: Demark-Wahnefried W; Peterson B L; Winer E P; Marks L; Aziz N; Marcom P K; Blackwell K; Rimer B K
Changes in weight, body composition, and factors influencing energy balance among premenopausal breast cancer patients receiving adjuvant chemotherapy.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2001;19(9):2381-9.
2001: Partridge A H; Bunnell C A; Winer E P
Quality of life issues among women undergoing high-dose chemotherapy for breast cancer.
Breast disease 2001;14():41-50.
2001: Partridge A H; Burstein H J; Winer E P
Side effects of chemotherapy and combined chemohormonal therapy in women with early-stage breast cancer.
Journal of the National Cancer Institute. Monographs 2001;(30):135-42.
2001: Winer E P; Burstein H J
New combinations with Herceptin in metastatic breast cancer.
Oncology 2001;61 Suppl 2():50-7.
2000: Carlson R W; Anderson B O; Bensinger W; Cox C E; Davidson N E; Edge S B; Farrar W B; Goldstein L J; Gradishar W J; Lichter A S; McCormick B; Nabell L M; Reed E C; Silver S M; Smith M L; Somlo G; Theriault R; Ward J H; Winer E P; Wolff A;
NCCN Practice Guidelines for Breast Cancer.
Oncology (Williston Park, N.Y.) 2000;14(11A):33-49.
2000: Burstein H J; Winer E P
Primary care for survivors of breast cancer.
The New England journal of medicine 2000;343(15):1086-94.
2000: Partridge A; Winer E
Use of taxanes in the treatment of patients with breast cancer has increased dramatically over the past 8 years.
Clinical breast cancer 2000;1(2):164-5.
2000: Baidas S M; Winer E P; Fleming G F; Harris L; Pluda J M; Crawford J G; Yamauchi H; Isaacs C; Hanfelt J; Tefft M; Flockhart D; Johnson M D; Hawkins M J; Lippman M E; Hayes D F
Phase II evaluation of thalidomide in patients with metastatic breast cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2000;18(14):2710-7.
2000: Miron A; Schildkraut J M; Rimer B K; Winer E P; Sugg Skinner C; Futreal P A; Culler D; Calingaert B; Clark S; Kelly Marcom P; Iglehart J D
Testing for hereditary breast and ovarian cancer in the southeastern United States.
Annals of surgery 2000;231(5):624-34.
2000: Speice J; Harkness J; Laneri H; Frankel R; Roter D; Kornblith A B; Ahles T; Winer E; Fleishman S; Luber P; Zevon M; McQuellon R; Trief P; Finkel J; Spira J; Greenberg D; Rowland J; Holland J C
Involving family members in cancer care: focus group considerations of patients and oncological providers.
Psycho-oncology 2000;9(2):101-12.
2000: Burstein H J; Manola J; Younger J; Parker L M; Bunnell C A; Scheib R; Matulonis U A; Garber J E; Clarke K D; Shulman L N; Winer E P
Docetaxel administered on a weekly basis for metastatic breast cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2000;18(6):1212-9.
2000: Dawson N A; Conaway M; Halabi S; Winer E P; Small E J; Lake D; Vogelzang N J
A randomized study comparing standard versus moderately high dose megestrol acetate for patients with advanced prostate carcinoma: cancer and leukemia group B study 9181.
Cancer 2000;88(4):825-34.
1999: Hensley M L; Schuchter L M; Lindley C; Meropol N J; Cohen G I; Broder G; Gradishar W J; Green D M; Langdon R J; Mitchell R B; Negrin R; Szatrowski T P; Thigpen J T; Von Hoff D; Wasserman T H; Winer E P; Pfister D G
American Society of Clinical Oncology clinical practice guidelines for the use of chemotherapy and radiotherapy protectants.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1999;17(10):3333-55.
1999: Burstein H J; Ramirez M J; Petros W P; Clarke K D; Warmuth M A; Marcom P K; Matulonis U A; Parker L M; Harris L N; Winer E P
Phase I study of Doxil and vinorelbine in metastatic breast cancer.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1999;10(9):1113-6.
1999: Kantoff P W; Halabi S; Conaway M; Picus J; Kirshner J; Hars V; Trump D; Winer E P; Vogelzang N J
Hydrocortisone with or without mitoxantrone in men with hormone-refractory prostate cancer: results of the cancer and leukemia group B 9182 study.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1999;17(8):2506-13.
1999: Parmigiani G; Berry D A; Winer E P; Tebaldi C; Iglehart J D; Prosnitz L R
Is axillary lymph node dissection indicated for early-stage breast cancer? A decision analysis.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1999;17(5):1465-73.
1999: Costanza M E; Weiss R B; Henderson I C; Norton L; Berry D A; Cirrincione C; Winer E; Wood W C; Frei E; McIntyre O R; Schilsky R L
Safety and efficacy of using a single agent or a phase II agent before instituting standard combination chemotherapy in previously untreated metastatic breast cancer patients: report of a randomized study--Cancer and Leukemia Group B 8642.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1999;17(5):1397-406.
1999: Winer E P; Lindley C; Hardee M; Sawyer W T; Brunatti C; Borstelmann N A; Peters W
Quality of life in patients surviving at least 12 months following high dose chemotherapy with autologous bone marrow support.
Psycho-oncology 1999;8(2):167-76.
1999: Bluman L G; Rimer B K; Berry D A; Borstelmann N; Iglehart J D; Regan K; Schildkraut J; Winer E P
Attitudes, knowledge, and risk perceptions of women with breast and/or ovarian cancer considering testing for BRCA1 and BRCA2.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1999;17(3):1040-6.
1999: Goss P E; Winer E P; Tannock I F; Schwartz L H
Randomized phase III trial comparing the new potent and selective third-generation aromatase inhibitor vorozole with megestrol acetate in postmenopausal advanced breast cancer patients. North American Vorozole Study Group.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1999;17(1):52-63.
1999: Havlin K A; Ramirez M J; Legler C M; Harris L N; Matulonis U A; Hohneker J A; Hayes D F; Winer E P
Inability to escalate vinorelbine dose intensity using a daily x3 schedule with and without filgrastim in patients with metastatic breast cancer.
Cancer chemotherapy and pharmacology 1999;43(1):68-72.
1998: Tengs T O; Winer E P; Paddock S; Aguilar-Chavez O; Berry D A
Testing for the BRCA1 and BRCA2 breast-ovarian cancer susceptibility genes: a decision analysis.
Medical decision making : an international journal of the Society for Medical Decision Making 1998;18(4):365-75.
1998: Bunnell C A; Winer E P
Oral 5-FU analogues in the treatment of breast cancer.
Oncology (Williston Park, N.Y.) 1998;12(10 Suppl 7):39-43.
1998: Warmuth M A; Bowen G; Prosnitz L R; Chu L; Broadwater G; Peterson B; Leight G; Winer E P
Complications of axillary lymph node dissection for carcinoma of the breast: a report based on a patient survey.
Cancer 1998;83(7):1362-8.
1998: Iglehart J D; Miron A; Rimer B K; Winer E P; Berry D; Shildkraut M J
Overestimation of hereditary breast cancer risk.
Annals of surgery 1998;228(3):375-84.
1998: Frank T S; Manley S A; Olopade O I; Cummings S; Garber J E; Bernhardt B; Antman K; Russo D; Wood M E; Mullineau L; Isaacs C; Peshkin B; Buys S; Venne V; Rowley P T; Loader S; Offit K; Robson M; Hampel H; Brener D; Winer E P; Clark S; Weber B; Strong L C; Thomas A
Sequence analysis of BRCA1 and BRCA2: correlation of mutations with family history and ovarian cancer risk.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1998;16(7):2417-25.
1998: Thomason T E; McCune J S; Bernard S A; Winer E P; Tremont S; Lindley C M
Cancer pain survey: patient-centered issues in control.
Journal of pain and symptom management 1998;15(5):275-84.
1998: Rimer B K; Sugarman J; Winer E; Bluman L G; Lerman C
Informed consent for BRCA1 and BRCA2 testing.
Breast disease 1998;10(1-2):99-114.
1998: Lindley C; Vasa S; Sawyer W T; Winer E P
Quality of life and preferences for treatment following systemic adjuvant therapy for early-stage breast cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1998;16(4):1380-7.
1997: Tessaro I; Borstelmann N; Regan K; Rimer B K; Winer E
Genetic testing for susceptibility to breast cancer: findings from women's focus groups.
Journal of women's health / the official publication of the Society for the Advancement of Women's Health Research 1997;6(3):317-27.
1997: Demark-Wahnefried W; Rimer B K; Winer E P
Weight gain in women diagnosed with breast cancer.
Journal of the American Dietetic Association 1997;97(5):519-26, 529; quiz 527-8.
1997: Demark-Wahnefried W; Hars V; Conaway M R; Havlin K; Rimer B K; McElveen G; Winer E P
Reduced rates of metabolism and decreased physical activity in breast cancer patients receiving adjuvant chemotherapy.
The American journal of clinical nutrition 1997;65(5):1495-501.
1997: Warmuth M A; Sutton L M; Winer E P
A review of hereditary breast cancer: from screening to risk factor modification.
The American journal of medicine 1997;102(4):407-15.
1997: Berry D A; Parmigiani G; Sanchez J; Schildkraut J; Winer E
Probability of carrying a mutation of breast-ovarian cancer gene BRCA1 based on family history.
Journal of the National Cancer Institute 1997;89(3):227-38.
1997: Sutton L M; Warmuth M A; Petros W P; Winer E P
Pharmacokinetics and clinical impact of all-trans retinoic acid in metastatic breast cancer: a phase II trial.
Cancer chemotherapy and pharmacology 1997;40(4):335-41.
1996: Fee-Fulkerson K; Conaway M R; Winer E P; Fulkerson C C; Rimer B K; Georgiade G
Factors contributing to patient satisfaction with breast reconstruction using silicone gel implants.
Plastic and reconstructive surgery 1996;97(7):1420-6.
1996: Chu L; Sutton L M; Peterson B L; Havlin K A; Winer E P
Continuous infusion 5-fluorouracil as first-line therapy for metastatic breast cancer.
The Journal of infusional chemotherapy 1996;6(4):211-6.
1995: Winer E P; Chu L; Spicer D V
Oral vinorelbine (Navelbine) in the treatment of advanced breast cancer.
Seminars in oncology 1995;22(2 Suppl 5):72-8; discussion 78-9.
1994: Rowinsky E K; Noe D A; Trump D L; Winer E P; Lucas V S; Wargin W A; Hohneker J A; Lubejko B; Sartorius S E; Ettinger D S
Pharmacokinetic, bioavailability, and feasibility study of oral vinorelbine in patients with solid tumors.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1994;12(9):1754-63.
1994: Winer E P
Quality-of-life research in patients with breast cancer.
Cancer 1994;74(1 Suppl):410-5.
1994: Winer E P; Sutton L M
Quality of life after bone marrow transplantation.
Oncology (Williston Park, N.Y.) 1994;8(1):19-27; discussion 27-8, 31.
1993: Winer E P; Fee-Fulkerson K; Fulkerson C C; Georgiade G; Catoe K E; Conaway M; Brunatti C; Holmes V; Rimer B K
Silicone controversy: a survey of women with breast cancer and silicone implants.
Journal of the National Cancer Institute 1993;85(17):1407-11.
1993: Demark-Wahnefried W; Winer E P; Rimer B K
Why women gain weight with adjuvant chemotherapy for breast cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1993;11(7):1418-29.
1992: Trump D L; Smith D C; Ellis P G; Rogers M P; Schold S C; Winer E P; Panella T J; Jordan V C; Fine R L
High-dose oral tamoxifen, a potential multidrug-resistance-reversal agent: phase I trial in combination with vinblastine.
Journal of the National Cancer Institute 1992;84(23):1811-6.
1992: Panella T J; Smith D C; Schold S C; Rogers M P; Winer E P; Fine R L; Crawford J; Herndon J E; Trump D L
Modulation of O6-alkylguanine-DNA alkyltransferase-mediated carmustine resistance using streptozotocin: a phase I trial.
Cancer research 1992;52(9):2456-9.
1990: Brizel D M; Winer E P; Prosnitz L R; Scott J; Crawford J; Moore J O; Gockerman J P
Improved survival in advanced Hodgkin's disease with the use of combined modality therapy.
International journal of radiation oncology, biology, physics 1990;19(3):535-42.
1985: Rosenberg A; Winer E P; Cadman E
The use of adjuvant chemotherapy for breast cancer in a community practice.
Connecticut medicine 1985;49(5):281-5.

Sign-in to see more

Sign-in free and Explore the Exciting World of BiomedExperts:

NetworkView

Eric Winer

Research Profile (preview)

Disorders

Procedures

Chemicals & Drugs

Concepts & Ideas

Physiology

Network (preview)

Publications

Sign in free and see...

Visualized networks:

GeoTargeted Searches:

Research Profiles:

Geonetwork of Eric Winer (preview)

All Publications